A detailed history of Grey Fox Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Grey Fox Wealth Advisors, LLC holds 952 shares of LLY stock, worth $730,907. This represents 0.24% of its overall portfolio holdings.

Number of Shares
952
Previous 952 -0.0%
Holding current value
$730,907
Previous $862 Million 2.13%
% of portfolio
0.24%
Previous 0.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $690,076 - $865,406
952 New
952 $862 Million
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $2,795 - $3,283
9 Added 6.98%
138 $47.4 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $41,479 - $48,332
129 New
129 $47.2 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Grey Fox Wealth Advisors, LLC Portfolio

Follow Grey Fox Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Fox Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Fox Wealth Advisors, LLC with notifications on news.